Compare SEAT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEAT | DRIO |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | United States | United States |
| Employees | 768 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.6M | 60.6M |
| IPO Year | N/A | 2013 |
| Metric | SEAT | DRIO |
|---|---|---|
| Price | $8.03 | $7.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $18.06 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 109.0K | 6.0K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | $4.60 | $47.58 |
| P/E Ratio | ★ N/A | $6.04 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.42 | $0.38 |
| 52 Week High | $35.00 | $17.74 |
| Indicator | SEAT | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 48.37 |
| Support Level | $5.72 | $7.29 |
| Resistance Level | $10.27 | $9.46 |
| Average True Range (ATR) | 0.99 | 0.46 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 40.59 | 37.89 |
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.